findmyKOL

Harold Bays, MD

Enriched profile

Medical Director and President, Louisville Metabolic and Atherosclerosis Research Center (L-MARC) · Louisville Metabolic and Atherosclerosis Research Center (L-MARC)

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Louisville, KY · Southeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusLipoproteins and Cardiovascular Health+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2025NIH fundingNone on fileWhy? →

Harold Bays is Medical Director and President, Louisville Metabolic and Atherosclerosis Research Center (L-MARC) at Louisville Metabolic and Atherosclerosis Research Center (L-MARC). OpenAlex indexes 501 publications with 32,856 citations (h-index 87); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 17 Aug 2026

Overview

Updated 15 Oct 2026

Harold Bays, MD, is Medical Director and President, Louisville Metabolic and Atherosclerosis Research Center (L-MARC). The public record shows 501 publications with 32,856 citations (h-index 87), centered on Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Pharmacology and Obesity Treatment. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 14 companies.

  • Most recent indexed publication: 2026 · Journal of medical economics
  • Top research focus: Lipoproteins and Cardiovascular Health
  • 14 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 14 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Obesity5 trialsOverweight4 trialsInsulin Resistance2 trialsType 2 Diabetes1 trialHypertriglyceridemia1 trialChronic Kidney Disease1 trialRenal Insufficiency1 trialOsteoarthritis1 trialDyslipidemia / Lipid Disorders

Research focus

OpenAlex concept fingerprint
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsPharmacology and Obesity TreatmentDiabetes Treatment and ManagementCancer, Lipids, and Metabolism

Drugs & molecules

across trials, industry payments and publications
Nexletolgeneric · Bempedoic acidClinical trials—Industry payments16Publications6Wegovygeneric · SemaglutideClinical trials—Industry payments13Publications3Repathageneric · EvolocumabClinical trials—Industry payments1Publications1Nexlizetgeneric · Bempedoic acid / ezetimibeClinical trials—Industry payments16Publications—Saxendageneric · LiraglutideClinical trials—Industry payments4Publications—Eyleageneric · AfliberceptClinical trials—Industry payments3Publications—Arcalystgeneric · RilonaceptClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials3Industry payments98Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments50Novo Nordisk IncClinical trials—Industry payments21Amgen Inc.Clinical trials—Industry payments17Esperion Therapeutics, Inc.Clinical trials—Industry payments16Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments14Merck Sharp & Dohme LLCClinical trials—Industry payments11Louisville Metabolic and Atherosclerosis Research CenterClinical trials4Industry payments—Novo Nordisk ASClinical trials—Industry payments3Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments3CargillClinical trials2Industry payments—Elcelyx Therapeutics, Inc.Clinical trials2Industry payments—Lilly USA, LLCClinical trials—Industry payments2Pfizer Inc.Clinical trials—Industry payments2Boehringer Ingelheim International GmbHClinical trials—Industry payments1Daiichi Sankyo Europe GmbHClinical trials—Industry payments1ERX PharmaceuticalsClinical trials1Industry payments—Essentialis, Inc.Clinical trials1Industry payments—Kiniksa Pharmaceuticals International, plcClinical trials—Industry payments1OBEcure Ltd.Clinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
501publications

Distinct works indexed by OpenAlex, matched via ORCID; 12 in PubMed.

32,856citations

Total citations across indexed works.

87h-index

Hirsch index (OpenAlex). i10-index 261.

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials ↓
14companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record
  • Co-author/advocate

    "Obesity and Advocacy: A Joint Clinical Perspective and Expert Review from the Obesity Medicine Association and the Obesity Action Coalition" (2024): supports the Treat and Reduce Obesity Act (TROA) …

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 15 Oct 2026

4 congress contributions (2005–2020) across AACE, ADA per OpenAlex. The most recent:

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Christie M. Ballantyne65Lawrence A. Leiter33Michael H. Davidson32Andrew M. Tershakovec30Ralph T. Doyle28Kausik K. Ray26Kevin C. Maki25Alberico L. Catapano25Peter H. Jones25John J.P. Kastelein24Rene A. Braeckman22Paresh N. Soni22James M. McKenney21Evan A. Stein20Peter P. Tóth20Ulrich Laufs19Yale Mitchel19Rebecca A. Juliano18Joanne E. Tomassini17Carlos A. Dujovne17Darbie Maccubbin17W. Virgil Brown17Angela Fitch17Maciej Banach16Scott Conard15William G. Stirtan15Sephy Philip15P. Barton Duell14Arvind Shah14Terry A. Jacobson14Michel Farnier13Christine McCrary Sisk13Antonio M. Gotto13Anne C. Goldberg12G.B. John Mancini11Deborah B. Horn11LeAnne T. Bloedon11Carl E. Orringer11Evan A. Stein11Robert H. Knopp11

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Board Certified

    Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Board Certified

    Endocrinology, Diabetes and Metabolism

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Diplomate

    American Board of Obesity Medicine (DABOM)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗

Editorial & leadership roles

journal and society appointments
  • Chairman

    National Lipid Association 2012 Adiposity and Dyslipidemia Consensus Conference

    2012
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
  • Chairman

    2010 American Association of Clinical Endocrinologists Adipose Tissue Pathophysiology State of the Science Conference

    2010
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
  • Chief Science Officer

    Obesity Medicine Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Past President

    Obesity Medicine Association

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Editor-in-Chief

    Obesity Pillars

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Fellow

    The Obesity Society (FTOS)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Fellow

    National Lipid Association (FNLA)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Fellow

    American Society for Preventive Cardiology (FASPC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗
  • Fellow

    American Association of Clinical Endocrinologists (FACE)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Clinical Associate Professor

    University of Louisville School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →obesitymedicine.org ↗

Media & interviews

press, podcasts and appearances
  • Video interview

    "Harold Bays, MD: A Different World for Obesity Treatment", HCPLive

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
  • Video interview

    "Harold Bays, MD: Considering the Future of Anti-Obesity Medications", HCPLive

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.